Marty Jablow DMD, Dental News and Technology

PDS Health Expands Epic Into Academic Settings

2026-04-10T13:02:00.005-04:00

First-of-its-kind academic deployment across medical, dental, and ambulatory surgical settings advances dental-medical integration and revenue cycle performance.

University of the Pacific and PDS Health Technologies are partnering to build a more integrated foundation for clinical education, patient care and operations across medical, dental and ambulatory surgical settings.

PDS Health Technologies announced today a formal partnership with University of the Pacific (Pacific) to implement its dental-optimized instance of Epic, the nation’s preeminent electronic health record (EHR) system, across the Arthur A. Dugoni School of Dentistry and Pacific Health Care Collaborative. This collaboration marks a milestone in health sciences education: Pacific will become the first dental school in the nation to implement PDS Health Technologies’ specialized platform across dental, medical, and a future ambulatory surgical center, creating a more integrated model for clinical education and care.

PDS Health Technologies will deliver a unified platform across Pacific’s San Francisco and Sacramento campuses, bringing multiple care settings onto the same patient record. The result is a more integrated environment for patients, students, and clinicians, with stronger visibility across care settings and a more complete view of health information.

“This partnership reflects a shared belief that oral health must be more meaningfully integrated with overall health,” said Preston Raulerson, president of PDS Health Technologies. “By bringing medical, dental, and future surgical care settings onto the same patient record, University of the Pacific is advancing dental-medical integration in a way that strengthens both education and patient care. We are proud to support that vision with a proven instance of Epic optimized for dentistry and backed by real-world clinical and operational performance.”

Dr. Elisa Chávez, interim dean at the Arthur A. Dugoni School of Dentistry, said, “Integrating PDS Health Technologies’ instance of Epic into our clinical and academic environments across three distinct care settings is a transformative step. This implementation allows our students to practice true interdisciplinary care and prepares our graduates for a future where oral health is recognized as an indispensable component of primary care.”

At the Arthur A. Dugoni School of Dentistry, the platform will help extend classroom instruction into the clinical setting in a more meaningful way. With access to more complete patient information and real-time interoperability, students and faculty will be better positioned to support interdisciplinary collaboration, strengthen referral coordination, and apply the principles of dental-medical integration in real clinical environments.

“This partnership allows us to modernize our clinical technology architecture around a single, interoperable EHR,” said Raybel Ramos, associate dean of information technology at the Arthur A. Dugoni School of Dentistry. “PDS Health Technologies’ dental-optimized Epic instance gives us the performance, security, and scalability needed to support complex academic and clinical workflows while ensuring that data flows seamlessly across care settings. It’s a critical step in building a future-ready digital ecosystem for our students and clinicians.”

This strategic collaboration also establishes a stronger model for academic health environments, where education, clinical care, and operations are aligned on a single foundation. Together, PDS Health Technologies and Pacific are building infrastructure that supports the current patient experience while laying the groundwork for future advancement in clinical research, data insights, and integrated care delivery.

In addition to the Epic implementation, PDS Health Technologies will provide its revenue cycle managed services to help align clinical and operational performance across Pacific’s care settings. This support is designed to strengthen operational workflows, improve financial performance, and help create a more integrated academic and clinical environment.

The PDS Health Technologies platform is distinguished by its superior clinical performance, revenue cycle alignment, and robust, real-time interoperability with comprehensive health records. Supporting over 14 million unique patients, it represents the most rigorously tested and widely adopted dental-optimized instance of Epic in the world. This high-performance infrastructure currently serves as the technological backbone for multiple academic institutions and multi-state healthcare organizations across more than 1,250 sites of care.

For more information, visit pdshealthtechnologies.com.

About PDS Health Technologies

PDS Health Technologies delivers scalable health technology, revenue cycle services, consulting, and operations management for dental and medical organizations advancing integrated, connected care. Its dental-optimized performance platform aligns workflows, interoperability, data analytics, and patient experience to unite care teams, streamline documentation, and strengthen operational and financial performance. In addition to its performance platform and revenue cycle management services, the business provides staffing and advisory services to help partners optimize their technology, elevate patient and provider experience, and improve overall performance. For more information, visit pdshealthtechnologies.com.

About University of the Pacific

Founded in 1851, Pacific is California’s first and oldest university. The Northern California school, with nearly 7,000 students in more than 130 academic programs across campuses in Stockton, Sacramento, and San Francisco, is ranked in the Top 100 of American colleges and universities by The Wall Street Journal.

The hallmark of a Pacific education is immersive learning, one-on-one relationships with faculty and advisors, and experiential learning opportunities on and off its campuses. Pacific ranks No. 36 in social mobility nationally and is in the Top 2% in career earnings. Pacific also is the nation’s top private university designated by the U.S. Department of Education as both a Hispanic-Serving Institution and Asian American and Native American Pacific Islander-Serving Institution. It is ranked No. 4 for “Best Value” among all California schools. Learn more at pacific.edu.

About PDS Health

PDS Health continues the journey started by Pacific Dental Services in 1994, with a vision to redefine healthcare through the integration of dental and medical services. Its approach, centered on the connection between oral health and overall health, aims to create healthier, happier patients and set new benchmarks in the healthcare industry. As a leading provider of integrated healthcare support, the company delivers a broad spectrum of services to dental, dental specialties, and medical providers, enhancing operations and care delivery for clinicians across the U.S.

For more information about PDS Health and its vision, visit pdshealth.com.

Epic® is a registered trademark of Epic Systems Corporation.

Premier Dental Unveils MultiMatch Flow Chameleon Composite

2026-04-09T15:52:00.004-04:00

Premier Dental proudly announces the introduction of MultiMatch Flow Chameleon Antimicrobial Composite with BioArmor—the next evolution in flowable composite engineered to deliver active protection, superior adaptability, and long-term clinical performance.

MultiMatch Flow represents a significant advancement in restorative dentistry. Today’s clinicians demand materials that go beyond esthetics and function—they want solutions that actively support long-term oral health in the face of biofilm, acid exposure, and demineralization. MultiMatch Flow meets this need by combining esthetic simplicity with BioArmor, a breakthrough antimicrobial nanotechnology.

At the core of this innovation, BioArmor leverages spherical mesoporous nano-silica particles infused with octenidine dihydrochloride (OCT), a broad-spectrum antimicrobial agent with a long history of safe clinical use. BioArmor is engineered for controlled, long-term OCT release, providing penetration through biofilm and supporting sustained antimicrobial efficacy. The result is a restorative material that does more than fill—it actively protects.

MultiMatch Flow Indications for Use—Cleared by the FDA:

Direct restorations in all cavity classes (I–V)
Base / liner under direct restoration
Veneering of discolored anterior teeth
Splinting of mobile teeth
Extended pit and fissure sealing in molars and premolars
Repair of composite/ceramic veneers
Retention of thermoplastic aligners

The addition of antimicrobial particles to MultiMatch Flow Chameleon Antimicrobial Composite reduces demineralization and the total amount of bacteria at the material surface, which is part of the caries formation process.

Key features include:

BioArmor Antimicrobial Protection – Lowers bacterial loads^1,5 with proven activity across a broad pH range⁶; also effective against other microorganisms such as fungus and viruses.
Defense Against Acid Challenges – Helps reduce demineralization² for added protective benefit.
Optimized Handling – Easy-flowing, self-leveling behavior supports smooth placement and excellent adaptation.
Low Shrinkage + Strong Physical Properties – Helps maintain marginal integrity and supports long-term durability.³
EZ-BlendTM Shade Simplicity – One universal shade that blends seamlessly with all 16 VITA classical A1–D4 shades.⁴

New MultiMatch Flow Chameleon Antimicrobial Composite with BioArmor will be available in the U.S. through authorized distributors in May 2026. In addition, new MultiMatch (Packable) Universal Chameleon Restorative Composite will also be available in May 2026.

About Premier Dental

Premier Dental is dedicated to delivering Inspired Solutions for Daily Dentistry worldwide. For over 100 years, dental professionals have trusted Premier for innovative, standard-setting products that improve procedures, practices, and patient outcomes. Inspired by the work clinicians do every day, we are committed to providing effective, efficient solutions.

For More Information, please visit www.premierdentalco.com.

^{16 VITA classical A1–D4 is not a trademark of Premier® Dental Products Company.}

^{1–6 Data on file.}

Henry Schein’s Carina Digital Intraoral Sensors Enable Accurate Diagnoses

2026-04-08T15:52:00.005-04:00

Photo courtesy of Henry Schein.

A total digital sensor solution, the Carina Digital Intraoral Sensor from Henry Schein offers simplicity and versatility with 2 sizes for patient comfort. Carina is designed to provide image quality that aids in accurate diagnoses.

It can be used with dental positioning devices and holders to assist with aligning an x-ray source beam with the sensor and anatomy, which reduces the risk of retakes.

The Carina 1.5 Digital Intraoral Sensor delivers premium technology at an excellent value. Backed by an industry-leading 2-year warranty, the single size sensor provides outstanding image quality and integrates into your existing digital system. The Carina Mini (Size 1) is designed for children or patients with limited mouths or severe gag reflexes.

Discover the Carina commitment: a promise to deliver value, image quality, and reliable service and support. Click here to learn more.

New Study Finds Treatment for Common Jaw Disorder Reduces Stress Hormone by More Than 40%

2026-04-07T13:23:00.005-04:00

Clinical research published in the Journal of Prosthetic Dentistry links targeted bite therapy to reduced
cortisol levels in patients with temporomandibular disorders.

New clinical research, co-authored by Dr. Robert Kerstein, suggests that treating a common jaw disorder may help reduce physiological stress levels in affected patients.

The study, recently published in the Journal of Prosthetic Dentistry (Elsevier), found that patients with occlusomuscular temporomandibular disorders (TMD) experienced a significant reduction in salivary cortisol—a known biological marker of stress—after undergoing Disclusion Time Reduction (DTR) therapy, a computer-guided bite adjustment dental treatment designed to optimize bite function and markedly lower muscle activity.

Temporomandibular disorders affect the jaw joint and surrounding muscles and are often associated with symptoms such as facial pain, headaches, jaw clicking, and muscle tension. According to the National Institute of Dental and Craniofacial Research, an estimated 5–12% of Americans experience TMD, affecting millions of people nationwide.

While stress has long been associated with TMD symptoms, the relationship between jaw function and physiological stress responses has remained unclear. This new study sought to determine whether improving bite mechanics could influence measurable stress indicators in the body.

"Many patients with TMD report symptoms that seem closely tied to stress, including chronic jaw tension, frequent stress headaches, nightly bouts of tooth grinding and clenching, and jaw muscle fatigue," said Dr. Robert Kerstein, co-author of the study and a retired prosthodontist in Boston. "This study was designed to explore whether correcting bite mechanics could influence the body's stress response in a measurable way."

In the clinical study, researchers evaluated 30 patients diagnosed with occlusomuscular TMD by measuring their salivary cortisol levels before treatment and again one month after undergoing DTR therapy.

The results showed meaningful physiological improvements following treatment:

Average salivary cortisol levels dropped significantly, decreasing from 11.43 ng/mL before treatment to 6.57 ng/mL after therapy
Patients experienced an average 42% reduction in cortisol levels following treatment
Disclusion times, the duration teeth remain in frictional contact during chewing movements, were reduced dramatically from more than two seconds to approximately 0.28 seconds

"These findings provide objective evidence that improving occlusal function can influence measurable biological stress markers," said Kerstein. "By using computer-guidance to precisely adjust how long teeth frictionally interact during jaw movements, we were able to reduce abnormal muscle activity and induce a significant reduction in cortisol levels, solely through high-precision computer guided treatment. These reductions occurred without the use of nightguards, splints, Botox, TENS therapy, medications, or dietary interventions, which are common symptomatic treatments that never address the true underlying bite causation."

Researchers used the T-Scan 10 Novus digital occlusion analysis system (Tekscan Inc., Norwood, MA, USA), synchronized with surface electromyography (sEMG; BioEMG III, Bioresearch Assoc., Milwaukee, WI), to precisely measure and adjust bite dynamics during treatment.

In addition to improvements in bite function, the study found significant changes in muscle activity in the temporalis and masseter muscles, two key muscles involved in jaw movement and chewing.

The findings suggest that targeted, computer-guided occlusal adjustments influence the neuromuscular pathways associated with stress responses, markedly reducing cortisol production in patients with occlusomuscular TMD.

The study adds to growing interest in how physical conditions within the musculoskeletal and oral systems may influence broader physiological stress mechanisms. As conversations around cortisol and nervous system regulation continue to gain attention in both medical and consumer health discussions, this research highlights the potential role that oral biomechanics and dental neurophysiology may play in overall stress regulation.

Researchers say the findings underscore the importance of understanding the connection between dental neurologic function, neuromuscular activity, and systemic stress responses, particularly for individuals experiencing chronic jaw pain or dysfunction.

The study appears in the Journal of Prosthetic Dentistry.

Read the abstract:
https://www.thejpd.org/article/S0022-3913(26)00145-9/abstract

ScienceDirect version of record:
https://www.sciencedirect.com/science/article/abs/pii/S0022391326001459

About Robert Kerstein, DMD
Dr. Robert B. Kerstein earned his D.M.D. in 1983 and his Prosthodontic certificate in 1985 from Tufts University School of Dental Medicine, where he later served as a clinical professor of Fixed and Removable Prosthodontics for 13 years. Beginning in 1984, he has studied every generation of the T-Scan technology, from the original T-Scan I to the current T-Scan 10 Novus, and over the past four decades has become the leading authority in Computerized Occlusal Analysis. Dr. Kerstein has published extensively in leading dental journals and edited nine research volumes on T-Scan applications. A pioneer and academic advocate for digital occlusal technology, he teaches a measured, data-driven approach that improves bite-related treatment outcomes, enhances patient comfort, reduces prosthesis failure and remakes, and shortens overall treatment time. To learn more, visit www.drrobertkerstein.com.

Vatech’s Versatile HD Sensor Designed for Easy Placement in Patient’s Mouth

2026-04-06T12:28:00.004-04:00

The HD Sensor from Vatech features one of the thinnest CMOS sensors in the world, allowing for easy placement within the patient’s mouth. It is available in sizes 1.0, 1.5, and 2.0, offering optimal options for patient comfort and proper positioning.

Vatech’s HD Sensor is easy to use and designed to deliver clear and consistent images.

The HD Sensor is clinically usable at a wide range of exposure settings and consistently delivers optimal results. Practitioners benefit from a reduction of time-consuming and exposure-related retakes. Additionally, patients benefit from the reduction of radiation exposure. With this high sensitivity sensor, you can capture diagnosable images under any condition, even when using an old x-ray source, according to Vatech.

Featuring a theoretical resolution of 33.78 lp/mm, the HD Sensor provides the necessary high-resolution images for accurate diagnosis. New noise and artifact reduction image processing is designed to provide clear and consistent images and to make the HD Sensor one of the easiest to use in the market today.

For more information, call (888) 396-6872 or visit vatechamerica.com.

Yeshiva University Launches New College of Dental Medicine in Midtown Manhattan

2026-04-03T09:00:00.009-04:00

First New Dental School in NYC Since 1916

Innovative Three-Year Program and Community Clinic Speed Entry into the Profession and Expand Access to Care

NEW YORK, March 11, 2026 /PRNewswire/ -- Marking a major expansion of its health sciences program, Yeshiva University is launching a new College of Dental Medicine in Herald Square, establishing the first new dental school in New York City in more than a century. The new school introduces an accelerated, patient-focused model for clinical training and dental education, setting a new standard for preparing the next generation of dental leaders.

Yeshiva University's College of Dental Medicine (YUCDM) will be housed in a historic, newly reimagined 10-story building at Herald Square, placing advanced dental education at the center of Manhattan's academic, medical and civic life. Harnessing state-of-the-art technology for contemporary training, the facility brings together digital imaging, 3D printing, clinical instruction and progressive learning spaces in an environment designed to support intensive, hands-on education and collaboration at scale.

The YUCDM, accredited by the Commission on Dental Accreditation and registered by the New York State Education Department (NYSED), will enroll 150 students annually beginning in July 2026 in an accelerated three-year program leading to a Doctor of Dental Surgery (DDS) degree. Offered by only a small number of dental schools nationwide, the model expedites the traditional four-year timeline while maintaining rigorous academic and clinical training—allowing students to enter the profession sooner and reduce the financial burden associated with an additional year of tuition and living expenses, without sacrificing depth or quality.

Designed to prioritize clinical readiness from the outset, the curriculum integrates academic rigor, hands-on experience and a mission-driven commitment to service. By rethinking how dentists are educated, YUCDM aims not only to expand the pipeline of highly trained clinicians in New York State, but to help define the future of dental education nationwide.

"The launch of Yeshiva University's College of Dental Medicine marks a defining moment for healthcare education in New York City and beyond," said Rabbi Dr. Ari Berman, President of Yeshiva University. "By establishing the city's first new dental school in more than a century, we are advancing a bold vision of clinical excellence, innovation and leadership—educating dentists who will shape the future of their profession with skill, values and a deep sense of responsibility to the communities they serve."

Central to YUCDM is Yeshiva Dental Health, a 130-chair clinical training facility. Designed to function as both a teaching center and a source of affordable, high-quality dental care, the clinic is expected to serve hundreds of patients each day while giving students early, sustained exposure to real-world clinical practice—reflecting YU's commitment to giving back to the community and expanding access to care in a city where dental services remain out of reach for many residents.

Expanding YU's Health Sciences Footprint
The YUCDM occupies the iconic Herald Center building at the corner of 34th Street and Broadway, originally constructed in 1902 as the flagship Saks department store. Its transformation into a center for dental education reflects a broader investment in revitalizing Midtown through academic presence, public health outreach, and professional training.

"I am incredibly proud to lead this remarkable effort," said Dr. Edward Farkas, Founding Dean of the YU College of Dental Medicine. "Our innovative three-year curriculum, integrated with state-of-the-art facilities and an unwavering focus on excellent patient care, will prepare our students for leadership in the practice environment of 2040 and beyond."

"This is an important moment for Yeshiva University and for New York City," said Dr. Selma Botman, Provost and Vice President for Academic Affairs. "The College of Dental Medicine reflects YU's academic standards and its longstanding commitment to using education as a force for public good."

The dental school becomes the newest addition to Yeshiva University's expanding portfolio of graduate health sciences programs, which includes occupational therapy, physician assistant, speech-language pathology, and a fast-track nursing program launched in Fall 2024. Together, these initiatives position the University as a growing force in healthcare education with a distinctly innovative and service-oriented focus.

The establishment of the College of Dental Medicine is being generously supported by major philanthropists including a $15 million leadership gift from philanthropists Morris Bailey and Joseph L. Jerome of JEMB Realty Corporation.

Dentistry continues to rank among the top careers in the nation. According to U.S. News & World Report, it remains one of the "Top 10 Best Jobs" for the sixth consecutive year, while the U.S. Bureau of Labor Statistics projects 8% growth in the field, with over 10,000 new positions expected by 2028.

SOURCE Yeshiva University

Boka Unveils Fluoride-Free Toothpaste for Sensitive Teeth

2026-04-02T08:45:00.004-04:00

The clinically backed formula combines 5% potassium nitrate and nano-hydroxyapatite in a Mint Cream flavor formulated to reduce and prevent painful tooth sensitivity.

Boka has launched Toothpaste for Sensitive Teeth, a new addition to its growing portfolio of fluoride-free, performance-driven oral care essentials. Designed for the millions of Americans who suffer from tooth sensitivity, the new toothpaste is formulated to reduce and prevent painful tooth sensitivity while remaining free from fluoride.

Boka’s new Toothpaste for Sensitive Teeth is designed to provide relief from pain and to relieve tooth sensitivity. Photo credit: Boka.

Boka’s Toothpaste for Sensitive Teeth provides relief from pain* and relieves tooth sensitivity* (*with twice daily brushing) for those seeking a better-for-you formula free from fluoride, parabens, and other harsh ingredients. The toothpaste combines 5% potassium nitrate, a clinically recognized ingredient that reduces painful tooth sensitivity, with nano-hydroxyapatite (n-Ha), a mineral that mimics the natural building blocks of tooth enamel. It reduces and prevents painful tooth sensitivity, builds protection against sensitivity from cold, heat, acids, and sweets, and freshens breath, all in a crave-worthy Mint Cream flavor with notes of mint, coconut, and cream. Unlike traditional sensitivity toothpastes, Boka’s formula is fluoride-free and made without parabens, SLS, artificial flavors, or dyes.

Boka, a leading modern oral care brand transforming daily routines with science-backed formulas that prioritize both efficacy and wellbeing, launched the new toothpaste as part of its strategic expansion to meet the needs of a broader audience–specifically, the millions of adults who experience tooth sensitivity and have historically had limited options that align with their ingredient standards. As more consumers seek effective relief without fluoride or harsh additives, Boka will bring a modern, science-backed approach to sensitivity care with its commitment to ingredient integrity, performance, and elevated daily rituals.

“Tooth sensitivity can take the joy out of eating and drinking, and for too long, consumers have been forced to choose between relief and fluoride-free formulations,” Sarah Mountcastle Mitchell, general manager at Boka, said in a press release announcing the launch. “With our new Toothpaste for Sensitive Teeth, we set out to deliver real protection and comfort for adults experiencing sensitivity–helping them enjoy the hot and cold foods they love again, while staying true to Boka’s standards for ingredient integrity, flavor, and overall wellness.”

Boka’s Toothpaste for Sensitive Teeth became available last month at Boka.com, Amazon.com, Walmart, and Target, and will be available at CVS later this month. The 4.0 oz size will be available at Boka.com and Amazon.com for $14, while the 3.4 oz size will be available online and in-store at Target and CVS for $11.99, and online and in-store at Walmart for $11.88.

For more information about Boka, visit www.boka.com and follow @boka on Instagram and @loveyourboka on TikTok.

DXPD Technology Allows AMD Lasers’ Acuity Sensor to Capture More Details

2026-04-01T13:17:00.005-04:00

The Acuity DXPD sensors are now available with lifetime warranties and reduced prices. Photo cr

The Acuity Direct X-Ray Photon Detection (DXPD™) intraoral sensor provides clearer, more detailed digital x-ray images than is possible with CMOS sensors. CMOS sensors experience significant data loss as they process x-ray photons into visible images. DXPD technology captures more x-ray data immediately, producing images with higher resolution and greater dynamic range while boosting users’ diagnostic confidence.

Each sensor comes with the Acuity Imaging Software package, providing everything a clinician needs. See what you’ve been missing, and rest easy knowing that every Acuity includes a 3-year warranty, and optional lifetime warranties are also available.

At the recent Chicago Midwinter Meeting, AMD Lasers introduced new pricing and a lifetime warranty for the Acuity DXPD intraoral sensor line, removing long-standing cost and replacement barriers associated with digital imaging systems.

DXPD represents the newest approach to direct x-ray photon detection, offering reduced photon loss and a thinner sensor profile compared with conventional CMOS-based sensors. Powered by proprietary DXPD sensor technology and imaging software, these sensors deliver exceptional diagnostic clarity and reliability. Available in Size 1 and Size 1.5, Acuity DXPD sensors are now priced at $1,995 per sensor or $2,995 with lifetime warranty. The lifetime warranty includes 2 complete sensor replacements during the life of the product to provide long-term confidence for practices.

For more information, call (866) 999-2635 or visit amdlasers.com.

VideaHealth Expands AI Across Emergency Dental Network

2026-04-01T12:15:24.120-04:00

Organization-wide rollout supports high-volume emergency care environments by reducing documentation burden for providers.

VideaHealth, the leading dental AI platform, today announces that Emergency Dental of America has deployed Videa across its network of 22 practices following a successful pilot. The rollout brings ambient clinical documentation to one of dentistry’s most demanding care settings, where providers often have limited time between patients to complete notes.

Emergency Dental of America operates a high-volume, same-day care model that requires efficient clinical handoffs and consistent documentation. Videa Voice Notes, the first AI-powered ambient scribe created specifically for dentistry, captures chairside dialogue between doctor and patient and turns it into structured, chart-ready SOAP notes that clinicians can review and finalize, reducing the need for up to two hours of after-hours charting per day while maintaining quality patient care.

“Emergency Dental of America practices maintain a strong focus on delivering attentive, high-quality patient care while ensuring clinical documentation remains thorough and timely,” said Dr. Roberto Monteagudo, Co-Founder and Chief Dental Officer of Emergency Dental of America. “Voice Notes has streamlined this process, allowing our providers to stay fully engaged with patients while maintaining accurate records. We’ve incorporated it as a standard component of our workflow as we continue expanding across the nation.”

Following positive feedback from pilot locations, Emergency Dental of America moved forward with an organization-wide rollout and established Voice Notes as a standard part of its clinical workflow. Using the platform, Emergency Dental of America is saving approximately 10 hours of provider time per week.

“Emergency Dental of America has always delivered exceptional care, and we’re proud to partner with them,” said Florian Hillen, Founder and CEO of VideaHealth. “With Videa Voice Notes, their teams can elevate the patient experience even further—capturing precise, comprehensive documentation while keeping every interaction focused on the patient.”

Emergency Dental of America joins a growing group of dental organizations using Videa Voice Notes to enable efficient clinical documentation in high-volume care environments, helping practices improve clinical workflows and reduce administrative burden.

About VideaHealth

VideaHealth is transforming dentistry with AI-powered solutions that help practices elevate care standards, improve productivity, and drive real business value. VideaAI, a comprehensive dental AI assistant, supports every aspect of dental care, from diagnostics and workflows to analytics and revenue optimization. Used by over 90,000 clinicians across more than 60 leading DSOs, VideaHealth’s FDA-cleared AI analyzes over 500 million X-rays annually, delivering trusted insights that power consistent, high-quality care. Headquartered in Boston and backed by leading investors, VideaHealth is advancing the future of dental care through responsible, real-world AI. Learn more at videa.ai.

About Emergency Dental of America

Founded in 2004 by Jared Derr, Emergency Dental of America opened its first office in Omaha, Nebraska, to address the growing need for emergency dental services. The company has since evolved into a full-service dental provider, offering a full spectrum of dental services beyond emergency treatment, with plans to roll out Voice Notes in the hygiene program. In 2016, Derr partnered with Dr. Roberto Monteagudo to spearhead the company’s nationwide expansion. Today, Emergency Dental of America operates 22 practices on Dentrix Core.

FlowRCM Launches AI-Powered Billing Platform Exclusively for Dental Practices

2026-03-31T13:13:00.005-04:00

FlowRCM LLC has announced the launch of FlowRCM, an AI-powered revenue cycle management platform built exclusively for dental practices and DSOs.

The average dental practice loses $50,000 to $150,000 annually to denied claims, billing errors, and missed appeal deadlines—most of which go unrecovered because staff simply don’t have the time to chase them.

Traditional billing services charge 5–9% of collections, costing practices thousands every month with little visibility into results.

FlowRCM changes that. The platform helps practices reduce claim denials before they happen, automatically recover denied claims, and eliminate the overhead of outsourced billing—all for a predictable flat monthly fee. Most practices recover the cost of the platform within the first month.

“Dental practices lose thousands every year to denied claims and billing inefficiencies. We built FlowRCM to fix that.” —FlowRCM LLC

FlowRCM is HIPAA-compliant and available now at flowrcmdental.com.

About FlowRCM LLC

FlowRCM is an Okemos, Michigan-based dental technology company helping dental practices and DSOs recover lost revenue through AI-powered billing automation.

April is National Facial Protection Month: Suit Up for Spring Sports and Outdoor Fun

2026-03-31T12:57:00.000-04:00

AAOMS and partner organizations urge families to make mouth guards, helmets and eye protection routine for sports and activities like biking and skateboarding.

ROSEMONT, Ill., March 31, 2026 /PRNewswire/ -- Spring sports season is back – and so are the fastballs, elbows, sticks and unexpected collisions that can turn a great game into an emergency dental visit. But organized sports aren't the only risk: everyday recreational activities like biking, skateboarding and scooters also can lead to painful and preventable injuries to the teeth, jaw and face.

Youth sports remain a leading source of preventable tooth and facial injuries, contributing toward a total average of 22,000 dental injuries occurring annually in children younger than 18, according to the American Academy of Pediatric Dentistry. With the right protective gear – and a few smart habits – many of these injuries can be avoided.

That's why, during National Facial Protection Month in April, four leading healthcare organizations are urging athletes, parents and coaches to make facial protection part of every practice, every game and every ride – not an afterthought once the season is underway. The initiative is led by the American Association of Oral and Maxillofacial Surgeons with collaborative support from the Academy for Sports Dentistry, the American Academy of Pediatric Dentistry and the American Association of Orthodontists.

Why facial protection matters

Tooth and facial injuries can be painful, costly and disruptive – and they often require follow-up care long after the final whistle. Each year, millions of children experience facial injuries while participating in sports and recreational activities, sometimes requiring extensive dental or medical treatment:

The American Academy of Pediatric Dentistry estimates dental injuries cost families between $500 million and $1.8 billion annually.
The Academy for Sports Dentistry reports sports-related injuries result in 20 million lost school days each year.
An American Association of Orthodontists survey found 99 percent of parents believe children in organized sports should wear mouth guards, yet 37 percent said their child never wears one while playing.
An American Association of Oral and Maxillofacial Surgeons study found many facial sports injuries result from ball collisions during baseball/softball.

The good news: many facial injuries can be prevented or mitigated with consistent use of well-fitted protective equipment.

Five ways to gear up for spring
To reduce the risk of dental and facial injuries this season, parents, caregivers, coaches and athletes can take these steps:

Make mouth guards routine: Use them at practice and games – and replace worn or ill-fitting guards. Custom-fitted mouth guards provide the best protection and comfort.
Check helmet fit and condition: A loose, outdated or damaged helmet doesn't protect as intended – whether it's for football, cycling, skateboarding or scooters.
Protect the eyes: Use sport-appropriate protective eyewear or goggles when risk is high.
Add facial coverage when available: Face shields/guards can reduce injury from balls, sticks, bats and contact in sports where facial impacts are common.
Use a quick safety check: Before play or a ride, take a few moments to confirm gear is in place and properly fitted.

"Spring sports and activities should be remembered for great plays and fun – not preventable injuries," said Robert S. Clark, DMD, President of the American Association of Oral and Maxillofacial Surgeons. "A mouth guard and properly fitted protective gear are small choices that can prevent major problems. If you're suiting up for the season, build facial protection into the routine from day one."

Take action
Before the first tournament, rivalry game or the first long bike ride of the season, families and coaches should confirm athletes and riders have sport-appropriate protective gear that fits properly – especially mouth guards, helmets and eye protection when indicated. Resources, safety checklists and guidance are available through each participating organization.

Also join the conversation on social media. Share prevention tips throughout April using #PlayItSafe.

About National Facial Protection Month
National Facial Protection Month is a collaborative initiative from the Academy for Sports Dentistry, the American Academy of Pediatric Dentistry, the American Association of Oral and Maxillofacial Surgeons and the American Association of Orthodontists.

Free Oral Cancer Screenings Offered Nationwide

2026-03-30T17:10:00.002-04:00

The Head and Neck Cancer Foundation will host its annual free oral cancer screening events across the country during Head and Neck Cancer Awareness Week, April 13–17, 2026. The foundation seeks to bring awareness and education around head and neck cancers and the importance of early detection. Now in its fourth year, participation in the screenings has grown to include 19 states and 60 dental and oral surgery offices across the United States. The non-invasive oral examination takes just a few minutes, and no appointment, insurance, or pre-registration is required.

Locations and dates can be found at www.mnofs.com/minnesota-oral-health-screening-event.

Head and neck cancers rank sixth among the most prevalent cancers in the United States, and roughly 50% of current diagnoses are considered late stage and difficult to treat. Globally, approximately 750,000 people are diagnosed with head and neck cancer annually, with 60,000 of those cases in the U.S., resulting in about 9,000 deaths in the U.S. each year. With an increasing pattern of affecting younger, non-smoker, and non-drinker patients, the Head and Neck Cancer Foundation encourages everyone to get screened.

“We host these free screening events to raise awareness and create opportunities for early detection of head and neck cancers,” said Dr. Deepak Kademani, founder of the Head and Neck Cancer Foundation. “These cancers are some of the most challenging and complex types to treat due to the significant effects on the overall quality of life for survivors. We encourage everyone to get screened, especially the elderly and those who have not been to a dentist or physician recently.”

The Head and Neck Cancer Foundation is dedicated to creating opportunities for the public to get screened and facilitating opportunities for early detection. If someone is unable to attend one of the free screenings, individuals are encouraged to visit their dentist at frequent, regular intervals, as dentists can help identify abnormalities that may require further attention. Donations to the foundation can also be made to help facilitate future screening events and patient resources. More information can be found at www.mnofs.com/head-neck-cancer-foundation.

About the Head and Neck Cancer Foundation

The mission of the Head and Neck Cancer Foundation is to raise awareness of this disease in our community and nation. Measurable and progressive change can be accomplished by strengthening education, awareness, research, outreach, and advocacy. Our ultimate goal is to save lives and improve outcomes for those affected by head and neck cancer. More information can be found at https://www.mnofs.com/head-neck-cancer-foundation.

BiteZen Wins Dental Tech Shark Tank, Secures Investment from Dentulu CEO and Expands Pilot Network with Leading Dental Labs

2026-03-30T09:04:00.007-04:00

CHICAGO, March 10, 2026 /PRNewswire/ -- BiteZen, a Colorado-based dental technology company, announced a strategic investment from Dr. Arash Hakhamian, Founder and CEO of Dentulu, following BiteZen's top prize win at the Dental Tech Shark Tank event during the 2026 Dental VIP Summit in Chicago.

Dental VIP Summit - Dental Tech Shark Tank Winner

Dr. Hakhamian has committed $50,000 in seed capital, and Dentulu is working with BiteZen to organize a Special Purpose Vehicle (SPV) intended to support the completion of the company's $1,000,000 seed round. The partnership also includes strategic collaboration to accelerate adoption of BiteZen's technology across dental labs and providers nationwide. Dentulu is one of the largest teledentistry networks connecting patients with licensed dentists through a digital care platform.

A recording of BiteZen's winning pitch from the Dental Tech Shark Tank event can be viewed here: Bitezen - Dental Tech Shark Tank

BiteZen's technology enables dental labs to embed sensing capabilities into traditional night guards and other oral appliances, allowing labs to convert standard appliances into connected devices capable of monitoring clenching, grinding, wear patterns, and patient compliance.

"Large manufacturers have spent years and millions building proprietary smart technologies. Most independent labs simply cannot absorb that level of R&D investment," said Dr. Hakhamian. "BiteZen gives them immediate access to smart capability without rebuilding their operation. That levels the playing field."

He added, "What excites me most about BiteZen is that this is not just a single-product company. The technology can extend across night guards, aligners, dentures, and other oral appliances. That platform potential is where long-term value is created."

BiteZen has secured six pilot partnerships with dental laboratories across the United States. Named partners include Drake Dental Lab and IDT Dental Lab.

"The lab market is becoming increasingly competitive," said Darrick Hartman, owner of JR Dental Lab. "Offering smart appliances powered by BiteZen allows us to differentiate in a meaningful way. Instead of competing on price alone, we can offer dentists measurable compliance and patient data."

In addition to Dr. Hakhamian's investment, Colorado-based venture capital firm Howdy Partners has committed $250,000 toward BiteZen's current seed round.

"Dr. Hakhamian's investment is more than capital. It is strategic validation from one of the most respected operators in dentistry," said Brock Predovich, Founder and CEO of BiteZen. "Dentulu's network and distribution capabilities dramatically accelerate our ability to scale."

BiteZen is focused on expanding pilot partnerships with dental laboratories and advancing commercialization of its sensing platform across the dental industry.

About BiteZen

BiteZen is a Colorado-based dental technology company dedicated to transforming traditional oral appliances into connected devices that enable data-driven insights for dentists, dental labs, and patients.

AquaSonic Launching New Electric Toothbrush in Target Stores Nationwide

2026-03-27T13:42:00.007-04:00

As consumers increasingly link oral health to overall wellness, the company expands its retail footprint in an effort to make modern oral care more accessible.

, AquaSonic is debuting its AquaSonic Precision Rechargeable Electric Toothbrush in hundreds of Target stores.

Under a new agreement with Target, AquaSonic is debuting its AquaSonic Precision Rechargeable Electric Toothbrush in hundreds of stores nationwide, launching in the large chain of stores for the first time.

“Our expansion with Target is a meaningful step forward in AquaSonic’s long-term growth strategy,” Arsalan Rahbarpoor, president and co-founder of AquaSonic, said in a press release. “By growing our retail footprint nationwide with Target, we’ll be able to introduce our innovative electric toothbrushes to new consumers across the US and help solidify our leadership in the evolving oral care landscape.”

AquaSonic’s launch in Target stores comes as consumer awareness of the link between oral health and overall wellness grows. A recent annual study found that more than 9 in 10 adults (91%) view their oral health as an important part of their overall health. At the same time, online conversations about wellness continue to gain traction, with consumers often sharing details of their daily self-care routines.

The rechargeable toothbrushes are available in rose gold and black models. Photos: courtesy of AquaSonic.

“Consumers are rethinking the everyday products they use and looking for oral care brands that deliver meaningful performance and value,” added Jonathan Cohen, chief marketing officer of AquaSonic. “Expanding into Target stores lets us make our premium, high-performance electric toothbrushes accessible to millions of households nationwide in one of the retail environments they trust the most.”

The launch of the AquaSonic Precision Rechargeable Electric Toothbrush at Target stores represents an important step in the company’s omnichannel growth strategy. The brand originally launched on Target.com in 2023. By expanding into Target stores, AquaSonic can introduce its modern oral care products to new audiences and create a seamless path to purchase for consumers who prefer in-store shopping.

The AquaSonic Precision Rechargeable Electric Toothbrush is available at Target in rose gold as well as in black. The toothbrush features 5 modes, 4 brush heads, a 2-minute timer, a travel case, and is available for $39.99. For more information, visit aquasonic.com.

Dentsply Sirona Advances Dental Imaging With MRI

2026-03-26T13:41:00.005-04:00

Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI¹ (ddMRI) system—MAGNETOM Free.Max Dental Edition—has received FDA clearance in the United States. This milestone follows the completion of a clinical trial² validating the system’s significant potential across multiple dental specialties. The trial highlighted this first-of-its-kind technology’s applicability in endodontics, periodontics, TMJ, tooth extraction, and orthodontics, offering non-ionizing imaging capabilities that can enhance diagnosis and treatment planning.

Dentsply Sirona and Siemens Healthineers are pleased to share key findings from the clinical trial validating their dental-dedicated MRI system. In addition to confirming its significant potential across multiple dental specialties, the trial also underscored the ddMRI system’s specialized features designed to meet the unique needs of dental professionals. Among these features is a dental-specific field of view, enabled by a dedicated dental coil and specialized software that focuses exclusively on dental structures, ensuring no brain tissue is visible and allowing for accurate imaging of dental structures. Additionally, the system’s ability to streamline patient preparation and maintain an average workflow time of under 20 minutes³ makes it a highly efficient tool for clinical use.

Clinical highlights from the trial demonstrated MAGNETOM Free.Max Dental Edition’s ability to differentiate active inflammation from healthy and scar tissue (see Figure 1), enable non-invasive assessment of tooth pulp vitality to support chairside testing and observations (see Figure 2), and enable the visualization of teeth and their position in relation to neighboring teeth as well as the nerves (see Figure 3).

“MAGNETOM Free.Max Dental Edition represents a significant advancement in dental imaging, providing excellent insights into dental structures that were not readily visible in other imaging modalities, without the risks associated with ionizing radiation. The ability to observe the same region of interest employing different ddMRI imaging sequences provides significantly more information regarding the pathological processes in hard and soft tissues, which results in a more accurate understanding of the lesion. This capacity to see the clarity of the soft tissue detail produced by ddMRI has clear potential to enhance diagnostic confidence in areas where current modalities have limitations,” said Prof. Don Tyndall, DDS, MSPH, PhD, FICD, FACD; Diplomate ABOMR, Professor of Diagnostic Sciences at University of North Carolina, who reviewed the clinical trial findings and collaborated in the FDA clearance process.

Dental-dedicated MRI: excellent complement to existing imaging solutions

As an ionizing radiation-free modality with advanced soft tissue contrast, ddMRI complements intraoral, panoramic, and CBCT imaging by addressing diagnostic questions where soft tissue characterization is critical.

MAGNETOM Free.Max Dental Edition, the first-of-its-kind dental-dedicated MRI, was developed jointly by Dentsply Sirona, Siemens Healthineers, and leading scientists in Europe and the United States. Specifically designed to enhance dentomaxillofacial diagnostics, ddMRI is primarily intended for hospitals, large clinics, and universities, and offers advanced soft tissue contrast through ionizing radiation-free imaging.

“This innovation is a powerful addition to our imaging portfolio, which includes Axeos, Orthophos SL, and Heliodent Plus, among others. We’re proud to have contributed to developing the industry’s first dental-dedicated MRI and the advancement of diagnostic capabilities in the field,” observed Dan Scavilla, President & CEO of Dentsply Sirona.

“We are dedicated to expanding the clinical impact and reach of MRI. We are excited to see the potential of ddMRI being validated through clinical trials, which will pave the way for a new clinical field that will benefit dental practitioners and patients alike,” said Andreas Schneck, Head of Magnetic Resonance at Siemens Healthineers.

Advanced Clinical Training

Clinicians interested in incorporating ddMRI into their practice can participate in an advanced, hands-on training program taking place in April 2026 at the University of Minnesota. This two-day course covers ddMRI imaging protocols, recommended clinical procedures, essential MR facility and patient safety guidelines, hands-on image acquisition, and practical interpretation sessions featuring TMJ and dental cases.

For more details, please visit Introduction to Dental MRI: A Hands-on Program | School of Dentistry.

Learn more at the upcoming American Dental Education Association (ADEA) Annual Session

Visit the Dentsply Sirona booth at the American Dental Education Association (ADEA 2026) Annual Session, taking place March 21–24 in Montréal, Canada, and learn more about the first dental-dedicated magnetic resonance imaging (ddMRI) system.

Learn more at www.dentsplysirona.com/ddmri.

About Dentsply Sirona

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands.

Dentsply Sirona’s innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY.

Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

DISCLAIMER

This information and any attachment thereto contain “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast,” and similar words and expressions. However, these words are not the exclusive means of identifying such statements.

In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share, and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties, and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market, and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions, and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.

Registered brands, trade names, and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for the use of their experiences and testimonials. Due to different approval and registration times, not all technologies and products are immediately available in all countries.

Please reach out to a local dealer or sales representative for more information.

JOMS Study: Reiki Therapy Before Wisdom Tooth Removal Did Not Reduce Anxiety, But Pain Scores Slightly Lower

2026-03-25T08:47:00.005-04:00

ROSEMONT, Ill., March 6, 2026 /PRNewswire/ -- A new study published in the January issue of the Journal of Oral and Maxillofacial Surgery (JOMS) found that Reiki – a touch-based therapy sometimes described as "energy healing" – did not reduce anxiety before wisdom tooth surgery. However, those patients who received Reiki did report slightly lower postoperative pain than those who had no interventions.

AAOMS

The study in JOMS – the official peer-reviewed journal of the American Association of Oral and Maxillofacial Surgeons (AAOMS) – was intended to evaluate whether Reiki – a nonpharmacologic, touch-based therapy that purports to facilitate energy transfer – affects perioperative anxiety in patients undergoing surgical removal of an impacted lower third molar, a common procedure in oral and maxillofacial surgery.

Researchers conducted a single-blind, randomized controlled trial involving 180 adults ages 18 to 45 undergoing treatment at Ege University Faculty of Dentistry in Izmir, Turkey. Participants were randomly assigned to one of three preoperative groups: Reiki therapy, sham Reiki (a placebo control that mimics treatment) or no intervention. Researchers measured anxiety using validated questionnaires and recorded postoperative pain daily for seven days using a visual analog scale; they also tracked analgesic use during the first postoperative week.

Key findings

Preoperative anxiety: No statistically significant differences were observed in anxiety levels between patients who received Reiki, sham Reiki or no intervention.
Postoperative pain: Average postoperative pain scores were lower in the Reiki group compared with no intervention. Pairwise comparisons did not show a significant difference between Reiki and sham Reiki.

The authors note that additional well-designed clinical trials are needed to better define Reiki's role in oral and maxillofacial surgical care.

Oral and maxillofacial surgeons use evidence-based approaches to manage anxiety and pain associated with wisdom tooth extraction, tailoring care to each patient's medical history, procedure complexity and individual needs. This study adds clinical trial data on a low-risk complementary intervention while underscoring that Reiki did not significantly reduce preoperative anxiety in this clinical setting.

The authors of "Does Reiki Therapy Reduce Preoperative Anxiety and Postoperative Pain in Third Molar Surgery? A Randomized Controlled Trial" are Meltem Ozden Yuce, PhD; Birant Simsek, PhD; Omer Faruk Dadas, PhD; and Candan Efeoglu, PhD.

The full article can be accessed at JOMS.org/article/S0278-2391(25)00758-X/abstract.

Learn more
Previous research published in JOMS has demonstrated that some nonpharmacologic strategies may help reduce anxiety during select oral and maxillofacial procedures, including:

Music therapy: A randomized clinical trial published in 2023, "Can Music Decrease Anxiety and Pain During Dental Implant Surgery? A Randomized Clinical Trial" found that listening to baroque and classical era music was associated with reduced anxiety in patients undergoing dental implant placement surgery. The full article can be accessed at JOMS.org/article/S0278-2391(22)00969-7/abstract.
Heartfulness meditation: A study published in 2021, "Effect of Heartfulness Meditation on Anxiety and Perceived Pain in Patients Undergoing Impacted Third Molar Surgery," reported reduced intraoperative anxiety following a single session of heartfulness meditation. The intervention did not significantly affect overall dental anxiety or perceived pain. The full article can be accessed at JOMS.org/article/S0278-2391(21)00413-4/abstract.
Aromatherapy: A study published in 2014, "Can Ambient Orange Fragrance Reduce Patient Anxiety During Surgical Removal of Impacted Mandibular Third Molars?" found that exposure to orange fragrance reduced anxiety associated with impacted third molar surgery. The full article can be accessed at JOMS.org/article/S0278-2391(14)00367-X/abstract.

About the Journal of Oral and Maxillofacial Surgery (JOMS)
The Journal of Oral and Maxillofacial Surgery is published by the American Association of Oral and Maxillofacial Surgeons to present to the dental and medical communities comprehensive coverage of new techniques, important developments and innovative ideas in oral and maxillofacial surgery. Practice-applicable articles help develop the methods used to handle dentoalveolar surgery, facial injuries and deformities, TMJ disorders, oral and head and neck cancer, jaw reconstruction, anesthesia and analgesia. The Journal also includes specifics on new instruments and diagnostic equipment, and modern therapeutic drugs and devices.

About AAOMS
The American Association of Oral and Maxillofacial Surgeons (AAOMS) represents more than 9,000 oral and maxillofacial surgeons in the United States. AAOMS surgeons specialize in treating diseases, injuries, and defects of the mouth, jaw and face. Learn more at AAOMS.org.

Henry Schein Opens Dallas Discovery Center

2026-03-24T08:46:00.004-04:00

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today celebrated the grand opening of its new Dallas Discovery Center (DDC)—an 8,300-square-foot, state-of-the-art training facility designed to bring health care education, technology, and innovation together under one roof. Located at 1080 S. Kimball Ave., Suite 160, Southlake, TX 76092, the center marks Henry Schein’s first integrated dental and medical training facility, reinforcing the Company’s commitment to advancing integrated, systemic models of health care delivery.

“Our goal with the Dallas Discovery Center is to create a collaborative space where clinicians, supplier partners, and our Team Schein Members can learn from one another and see what’s possible in health care,” said Ty Ford, Vice President and General Manager, Henry Schein U.S. Medical Sales. “By bringing medical and dental training together, we’re helping build a more integrated, patient-centric future.”

Located minutes from Henry Schein’s Southwest Distribution Center, the DDC features dedicated areas to demonstrate a fully equipped exam room, experience laboratories, an ambulatory surgery center site, a dental equipment showroom, and immersive learning environments. The tech-forward space enables customers to preview the latest equipment firsthand, supplier partners to showcase solutions from various manufacturers, and Team Schein Members (TSMs) to strengthen their expertise through real-world applications.

“Oral health and overall health are deeply interconnected,” said Steve Kizy, Vice President and General Manager, Henry Schein U.S. Dental Group. “Fostering closer alignment between dental and medical care, with a focus on prevention and wellness, can lead to better outcomes for patients and greater efficiency for providers.”

The launch event featured a ribbon-cutting ceremony, tours, and interactive demonstrations for supplier partners, Henry Schein leadership, and TSMs. Attendees explored hands-on stations highlighting emerging technologies, product innovations, and education programs designed to help practitioners maximize the performance of the solutions they use every day.

“Our commitment to education is ultimately a commitment to our customers,” said Kristen Meszaros, Director, Training and Development, Henry Schein. “This center enables us to develop sales professionals and leaders who deeply understand the environments our customers operate in, empowering them to serve as consultative partners who deliver insight, expertise, and long-term value—not just products.”

For more information about Henry Schein’s Dallas Discovery Center, please click here.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company’s sales reached $13.2 billion in 2025 and have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com.

ZimVie’s Molar Implant System Achieves Optimal Precision, Control, and Stability

2026-03-23T16:37:00.004-04:00

Clinicians can transform extractions into confident placements with the ZimVie Immediate Molar Implant System engineered for precision, control, and long-term success. The system expands the company’s TSX and T3 PRO dental implant lines.

The ZimVie Immediate Molar Implant System expands the company’s TSX and T3 PRO dental implant lines. Photo credit: ZimVie

The ZimVie Immediate Molar Implant System includes tools designed for easier site preparation and wide-diameter implants. Also, it is designed to help prevent peri-implantis and maintain crestal bone levels.Proprietary coronal Dual Acid-Etched (DAE) Surface may lower the risk of bio-film formation and peri-implantitis while supporting healthy crestal bone levels. Bacteria adhesion on the coronal DAE portion of the ZimVie Immediate Molar Implant is like that observed on a machined surface, but significantly less than on rougher surfaces such as laser-machined channels or those treated with alumina blasting, according to the company.

Other features include unmatched stability—overcome stability challenges in complex molar anatomy with the implant’s deep apical threads—and the wide coronal design, and specialized wide implants designed for secure engagement in diverse molar extraction anatomy. Also, 2 connections—Certain Internal Connection and TSV Friction-Fit Internal Hex—reportedly minimize micromotion and provide favorable conditions for crestal bone-level maintenance.

The ZimVie Immediate Molar Implant System includes a versatile Surgical Kit designed for efficiency and ease of use. Featuring an intuitive workflow and easy-to-navigate layout, the kit allows for quick identification of instruments and drilling depths with informative legends and logical organization.

For more information, visit zimvie.com.

AAP Highlights Connection Between Periodontal Disease and Cardiovascular Health

2026-03-20T12:56:00.005-04:00

In recognition of American Heart Month—recognized each year in February—the American Academy of Periodontology (AAP) has been highlighting a powerful and often overlooked connection between periodontal and cardiovascular health. Mounting evidence shows that gum disease is not just a dental issue; it may be a warning sign for serious heart conditions.

Several studies published in the AAP’s Journal of Periodontology (JOP) and a recent scientific statement from the American Heart Association (AHA) reveal that periodontal disease is independently associated with a higher risk of atherosclerotic cardiovascular disease, including heart attack, stroke, and heart failure. Chronic inflammation and harmful bacteria from infected gums can enter the bloodstream, potentially fueling plaque buildup in the arteries, underscoring why periodontists are urging closer collaboration with cardiologists, especially for patients at elevated risk.

“It is well known that both gum disease and heart disease share common risk factors, such as smoking, obesity, and diabetes,” AAP President and practicing periodontist Dr. Ana Becil Giglio stated in a press release. “Ongoing research continues to confirm that periodontal health is an indication of overall health, which makes oral health professionals such as periodontists adept at recognizing potential issues.”

While there is no proven causal relationship between gum disease and heart disease, a large body of research, including the recent AHA report, suggests that periodontal treatment can reduce inflammatory markers in the body which can benefit cardiovascular health.

The AAP and the AHA continue to advocate for collaborative, integrated care, where periodontists and cardiologists work together to manage their shared patients. According to Dr. Giglio, “You cannot be healthy unless your mouth is healthy, and that goes for your heart as well. For individuals at high cardiovascular risk, assessment and treatment by a periodontist may be an essential part of comprehensive care.”

Periodontal disease is a chronic, inflammatory disease that can damage the gums and compromise supporting structures around the teeth. Periodontists are specialists with advanced training in surgical and nonsurgical periodontal therapy, implant placement, and regenerative techniques. Periodontics is one of 12 dental specialties recognized by the American Dental Association.

For more information or to find an AAP member periodontist in your area, visit perio.org.

Dentalcorp Launches High-Stakes Dental Tech Competition

2026-03-19T15:54:18.309-04:00

Dentalcorp, one of North America’s largest dental support organizations, today announced its inaugural Demo Day, a live dental technology competition taking place June 24 at the Gaylord Palms Resort & Convention Center in Orlando, Florida. The event will award a US$100,000 SAFE investment and a potential pilot opportunity to the winning company, with access to a network of more than 600 practices serving 5.7 million patients annually.

Applications are open now through May 15. Up to ten finalists will be selected by May 22 and invited to deliver live technology demonstrations in front of an expert judging panel and an audience of dental industry executives, investors, and operators.

“We have built one of the most sophisticated dental networks in North America. The clinical standards, the operational infrastructure, the people who show up every day and make it work. What we are doing with Demo Day is opening that up. If you have built technology that can genuinely improve how dentistry is delivered, there is no better place to prove it. This is not a competition that hands out a cheque and moves on. We are a partner with 600+ practices and the expertise to help the right solution scale. This is the first edition of what we intend to build into the most important annual gathering of dental technology innovation in North America.” — Nate Tchaplia, President, Dentalcorp

A Proving Ground for Dental Innovation

Demo Day bridges the gap between promising dental technology and real-world clinical deployment, addressing a challenge that has historically slowed innovation across the dental industry. Rather than a traditional pitch competition, finalists will demonstrate their technology in action, respond to questions from the judging panel, and compete for a prize package built around clinical access and long-term growth, not just capital.

Eligible technologies include dental AI diagnostics, computer vision, imaging technology, workflow automation, predictive analytics, patient engagement, and practice management solutions. Companies at prototype, beta, or market-ready stages are all encouraged to apply.

What the Winner Receives

The winning company will receive:

US$100,000 SAFE (Simple Agreement for Future Equity) investment
A clinical pilot opportunity across Dentalcorp’s North American practice network
Strategic mentorship from Dentalcorp’s leadership and technology teams
Visibility before dental industry executives and investors attending the event

All finalists will receive a US$2,000 travel allowance and live demo exposure to a curated professional audience.

“What makes this different from most competitions is the deployment pathway. A SAFE investment is meaningful, but access to 600+ practices and 5.7 million patient touchpoints is a clinical validation opportunity that most dental startups never get. That is what the Dental Innovation Alliance looks for, and it is what the best founders in this space need.” — Kentucky Morrow, Partner, Dental Innovation Alliance

Expert Judging Panel

Submissions will be evaluated by a panel of dental industry leaders and technology investors, including:

Nate Tchaplia, President, Dentalcorp
Dr. Amarjit Rihal, Clinical Director of Operations, Dentalcorp
Kentucky Morrow, Partner, Dental Innovation Alliance (DIA)
Dr. Ryan Hungate, Chief Clinical and Strategy Officer, Henry Schein One
Dr. Zarah Ali, Director of Strategy & Growth, VideaHealth

Judges will evaluate submissions on clinical value, workflow integration, economic benefit for dental practices, commercialization potential, and strategic alignment with Dentalcorp’s vision of frictionless dentistry.

How to Apply

Applications are submitted through the official Dentalcorp Demo Day website at frictionlessdentistry.com. There is no application fee. Each applicant is limited to one submission. Finalists must be prepared to deliver a live technology demonstration at the Orlando event on June 24, 2026.

Key Dates

Applications open: March 16
Application deadline: May 15 at 11:59 p.m. EST
Finalists announced: May 22
Demo Day: June 24, Gaylord Palms Resort & Convention Center, Orlando, Florida

About Dentalcorp

Dentalcorp is one of the largest and fastest-growing dental support organizations in North America, operating a network of more than 600 practices with over 5.7 million patient visits annually. Dentalcorp partners with leading dental professionals to deliver technology-enabled care through its model of frictionless dentistry, removing the operational and administrative barriers that slow clinical excellence. For more information, visit dentalcorp.com.

About Dentalcorp Demo Day

Dentalcorp Demo Day is an annual live dental technology showcase that brings together the most promising dental AI, software, and software-enabled startups with the clinical network, capital, and mentorship needed to scale. The inaugural event takes place June 24, 2026 at the Gaylord Palms Resort & Convention Center in Orlando, Florida. Applications are open through May 15, 2026 at frictionlessdentistry.com.

Straumann’s SIRIOS X3 Delivers Seamless Intraoral Scanning

2026-03-19T12:29:00.004-04:00

SIRIOS X3 is fully integrated into the Straumann digital ecosystem via Straumann AXS, Photo credit: Straumann.

The SIRIOS X3 intraoral scanner offers a comprehensive set of benefits designed to elevate digital dentistry, enabling personalized treatment workflows and supporting a wide range of clinical indications.

It delivers a seamless intraoral scanning experience, especially in full-arch and complex cases. Its lightweight, ergonomic pen-grip design ensures comfort for both clinician and patient, while features like high-speed scanning, wireless fast charging, calibration-free readiness, and an LED ring guidance enhance usability and efficiency.

Clinicians gain flexibility with flexible scanning strategies and intelligent action menu, streamlining daily workflows. Beyond scanning, the Straumann SIRIOS X3 is fully integrated into the Straumann digital ecosystem via Straumann AXS, providing seamless access to multiple workflows including implant, orthodontic, surgical planning, and chairside 3D printing (with the Straumann Signature Midas by SprintRay). This open, cloud-based system ensures secure data handling, easy collaboration with labs, and access to outsourcing solutions like Smile in a Box and Straumann UN!Q.

Combined with superior training programs, reliable global support, and Straumann’s trusted legacy of innovation, the Straumann SIRIOS X3 empowers dental professionals with efficiency, precision, and tailored treatment possibilities. Ultimately, it transforms practice workflows and enhances patient care by uniting cutting-edge technology with premium service and connectivity.

For additional information, visit straumann.com/us/en/dental-professionals/digital-performance/equipment/io-scanners/straumann-sirios-x3.html.

AMD Lasers to Introduce Breakthrough Laser Root Canal Disinfection Technology at the 2026 AAE Annual Meeting

2026-03-18T12:07:00.001-04:00

Innovative integrated diode laser protocol achieves >99.99% bacterial reduction while simplifying endodontic workflow and reducing treatment time.

AMD Lasers, Inc., a subsidiary of the CAO Group, Inc. and a global leader in dental technology and manufacturing, today announced the launch of LEAP® (Laser Endodontic Ablation Procedure), a next-generation laser-assisted root canal disinfection system designed to deliver predictable, reliable, and affordable complete bacterial elimination while simplifying clinical workflow. The technology will be formally introduced at the 2026 American Association of Endodontists (AAE) Annual Meeting beginning April 15, 2026.

LEAP integrates the Picasso Pro™ diode laser, proprietary LEAP disinfection solution, and specially engineered LEAP fiber tips to create a complete laser-driven canal disinfection protocol. All LEAP elements and the overall protocol have been FDA-approved. Independent laboratory research demonstrates greater than 99.99% bacterial reduction against Enterococcus faecalis, one of the most persistent pathogens in endodontic infections.

Addressing a Two-Century Challenge in Endodontics

Canal disinfection is the most critical step in root canal treatment. Reliable and complete root canal disinfection has been sought by researchers and clinicians since modern endodontic therapy was first introduced more than 200 years ago. Conventional protocols rely primarily on chemical irrigation, most commonly using sodium hypochlorite. Some also combine ultrasonic or laser agitation techniques. While widely used, sodium hypochlorite presents challenges, including tissue toxicity risk, procedural complexity, and extended contact times required for improved antimicrobial effectiveness.

Following more than a decade of research and development, AMD scientists have developed a method that converts diode laser energy into controlled thermal ablation within the root canal system, eliminating residual bacteria through ablation while preserving surrounding cementum and periodontal ligament structures.

The LEAP tip, beginning at 200 μm in diameter, enables clinicians to reach the apical third of the canal with minimal canal enlargement, helping preserve natural tooth structure.

Integrated Laser Disinfection Platform

The LEAP system combines four key technologies: the Picasso Pro 810 nm diode laser, dedicated LEAP treatment protocol software, proprietary LEAP irrigation and disinfection solution, and disposable LEAP endodontic fiber tips. This integrated approach enables deep canal penetration, controlled thermal disinfection, and predictable bacterial reduction under low-energy laser parameters.

Independent laboratory testing has demonstrated >99.99% reduction of E. faecalis bacteria. Early clinical evaluation has also reported strong patient comfort outcomes, including 80% of patients reporting no pain within 24 hours of treatment and 100% reporting no pain after seven days.

Faster Workflow for Endodontic Procedures

The LEAP protocol simplifies traditional endodontic procedures and may also significantly reduce treatment time. Key workflow advantages include minimal file sequence and reduced dentin removal, reduced irrigation steps, and shorter solution exposure time. The LEAP protocol also eliminates the need for sodium hypochlorite in root canal treatment.

Together, these efficiencies may reduce endodontic procedure time by up to 50% while minimizing the potential for multi-visit treatments, improving chairside productivity and enhancing the patient experience.

Picasso Pro: A Multi-Purpose Clinical Platform

The Picasso Pro diode laser platform provides clinicians with a versatile tool for multiple dental procedures, including soft tissue surgery and management, laser-assisted pain alleviation (LAPA™) for painless injection, photobiomodulation (PBM) therapy, endodontic applications including LEAP, and future laser-induced reversible adhesive (LIRA™).

Key platform features of this 810 nm diode laser include its dedicated LEAP protocol mode, iPad-based interface with automatic software updates, and compact design for easy integration into dental operatories.

Clinical and Economic Advantages

LEAP was developed to deliver advanced endodontic technology at a practical price point. The MSRP for the Picasso Pro laser system will be under $10,000, and LEAP consumables carry less than a $30 per-procedure cost. Treatment time is reduced from an average of 90 minutes to 50 minutes, improving the patient experience while allowing clinicians to treat more patients per day. By combining advanced disinfection performance with accessible technology costs, LEAP allows practices to enhance patient care while improving operational efficiency.

Executive Commentary

“LEAP represents the first fully integrated diode laser protocol specifically designed for root canal disinfection and is a part of our continuous innovation in dentistry,” said Densen Cao, PhD, CEO of CAO Group, AMD’s parent company.

“By achieving greater than 99.99% bacterial reduction while eliminating sodium hypochlorite and significantly reducing procedure time, LEAP provides clinicians with a repeatable, reliable, and affordable canal disinfection technology. We believe this innovation represents a revolutionary advancement in dental root canal treatment.”

For more information about LEAP and Picasso Pro, please visit www.amdlasers.com or booth #1809 at the 2026 American Association of Endodontists Annual Meeting. AMD will provide comprehensive demos and lectures at the AAE booth.

Clinicians can also preview the Picasso Pro system and LEAP products at www.amdlasers.com.

About AMD Lasers

AMD Lasers, Inc. (AMD), a subsidiary of the CAO Group, Inc., is a global innovator and manufacturer in advanced dental technologies. AMD has created many innovations contributing to dentistry, including LED curing light, diode lasers, PVP teeth whitening thickener and viscoelastic gelatin strips, direct X-ray photon detection sensor, laser curing light, complete canal disinfection, and many others.

The Picasso diode laser product line has become one of the most widely adopted dental laser platforms worldwide. The company innovates and manufactures clinically proven products to make dentistry easier, faster, and better for practitioners and patients.

AAP Highlights Connection Between Periodontal Disease and Cardiovascular Health

2026-03-18T09:40:00.004-04:00

For more information or to find an AAP member periodontist in your area, visit perio.org.

DentScribe Receives Notice of Allowance for First U.S. Patent, Validating Its Agentic AI Platform for Dentistry

2026-03-17T09:57:00.004-04:00

News provided by

DentScribe

Allowed claims cover real-time dental speech capture, schema-driven structured SOAP generation, PMS-native publishing, and automated care-gap and revenue opportunity checklists via CoPilot and GPS.

SUNNYVALE, Calif., March 2, 2026 /PRNewswire/ -- DentScribe today announced it has received a Notice of Allowance from the United States Patent and Trademark Office for its first patent application: U.S. Patent Application Serial No. 18/593,903, titled "System, Method, and Apparatus for Automating Creation of Subjective, Objective, Assessment, and Plan (SOAP) Reports," filed March 2, 2024. The Notice of Allowance represents a major milestone for DentScribe and validates the foundational inventions behind DentScribe's agentic AI engine: technology designed to transform chairside conversations into structured clinical documentation and revenue-generating action.

What the allowed claims cover

The allowed claims protect a system that automates dental clinical documentation end-to-end, including:

Real-time operatory speech capture and transcription tuned for dentistry: including recognition of dental terminology such as tooth numbering schemes, periodontal charting terms, and orthodontic descriptors.
Structured clinical extraction using multiple parallel prompt modules: designed to extract standardized categories across the dental record (including periodontal findings, hard tissue findings, radiographic findings, orthodontic conditions, assessment, treatment plan, referrals, consent, and patient education) and aggregate them into a structured record.
Practice-specific Plan automation through template-to-CDT mapping: converting a practice's unstructured templates into a persistent mapping between CDT procedure codes and practice-specific procedural steps, then using that mapping to automatically populate the Plan section of the SOAP note.
PMS-native publishing: inserting the structured SOAP note directly into dental practice management systems using interfaces aligned to the PMS data model.
Automated chart review and opportunity surfacing: analyzing historical SOAP notes to detect unfinished, deferred, or overlooked treatments, generating a patient-specific checklist, and presenting it at the point of care.
Practice-wide daily operational dashboard: aggregating patient-level opportunities across the day's schedule into a dashboard segmented by provider, operatory, discipline, and production value tier to support morning huddles and daily execution.

Why this matters to dentistry

Documentation tools often stop at transcription. DentScribe's patented approach is designed to go further. It turns clinical conversation into structured documentation, then turns documentation into revenue, including chairside checklists and daily operational planning designed to catch all production opportunities. This is the basis of DentScribe's "closed loop" platform: capture → structure → publish → surface opportunities → execute.

"This Notice of Allowance is a landmark moment for DentScribe and for dental AI," said Dr. Vinni K. Singh, DDS, Founder & CEO of DentScribe. "It validates the core inventions we built to do what dentistry actually needs: listen in real time, understand clinical context, produce structured SOAP documentation, and then convert that documentation into follow-up actions that improve care delivery and increase production. This is the foundation for DentScribe's agentic platform, where the chart doesn't just get written; it gets used. This gives DentScribe a sophisticated moat against competitors."

Individual practices and Dental Support Organizations (DSOs) of all sizes leverage DentScribe's specialized capabilities to standardize clinical documentation. The platform transforms structured SOAP notes into strategic assets by converting documentation into follow-up actions that improve care delivery and increase production.

"Most systems capture words. This invention protects a system that captures clinical intent and operationalizes it," said Dr. Ratinder Paul Ahuja, PhD, Board Chair of DentScribe. "As an inventor, I'm excited by the scope and rigor of what's been allowed: real-time, schema-driven clinical extraction, deterministic structuring, and a closed loop from documentation into decision support and daily operations. This is the kind of foundational innovation that will define the next decade of AI in dentistry."

Availability

DentScribe's platform is available now for dental practices and DSOs. To learn more about DentScribe's agentic documentation suite, including chairside CoPilot checklists and GPS daily production planning, schedule a live demo.

Call to Action: Book a demo: https://www.dentscribe.ai/book-a-demo

About DentScribe
DentScribe is the AI platform for dental documentation and production. DentScribe automatically generates comprehensive SOAP notes from dentist-patient conversations and publishes them directly into leading practice management systems. With DentScribe CoPilot, those notes become chairside checklists that close care gaps and increase case acceptance. With DentScribe GPS, leaders gain a practice-wide daily brief that turns morning huddles into a reliable engine for production and patient outcomes. Founded by practicing dentist Dr. Vinni K. Singh in Sunnyvale, California, DentScribe helps dentists reclaim time, deliver better care, and grow their practices, without changing how they work.

Media Contact
hello@dentscribe.ai • 650-446-6161 • 710 Lakeway Dr. #200, Sunnyvale, CA 94085

SOURCE DentScribe

ADA Backs Legislation Protecting Dental Insurance Patients

2026-03-16T12:28:00.002-04:00

The American Dental Association (ADA) recently commended Rep. Jeff Van Drew (R-NJ) and Rep. Herb Conaway (D-NJ), for introducing the Improving Dental Administration (IDA) Act to ensure that the more than 360 state dental insurance reform/patient protection laws enacted in the last decade apply equally to enrolled patients of self-insured plans.

The Employee Retirement Income Security Act of 1974 (ERISA) regulates “self-funded” dental plans. Some dental carriers claim ERISA allows them to ignore state insurance laws meant to protect patients. The ADA wants to close that loophole and bring the power to regulate healthcare back where it belongs – with the states.

“The growing number of ‘self-funded’ plans regulated by ERISA has emboldened carriers to assert they are not subject to state oversight, claiming that the ERISA preemption gives them a free pass to ignore insurance laws,” said Rich Rosato, D.M.D., president of the American Dental Association. “We need to fix this ERISA loophole that keeps state regulators from enforcing pro-consumer insurance laws enacted in their states. Patients and providers should not be left unprotected based simply on how their dental benefits are purchased.”

This federal reform measure is necessary to address the “gray area” created by ERISA and to reassert states’ rights to regulate coverage offered in their state insurance market. Congress can clarify this ambiguity through legislation that would allow states to apply state passed legislation to ERISA plans. If this bill becomes law, it will make it clear that self-funded dental plans must adhere to state dental insurance laws.

“Insurance regulators are uncertain about how to hold carriers accountable to laws in their state when the carriers act as administrators for self-funded plans. This legislation takes a big step forward in creating fairness and accountability across the board,” said Dr. Rosato.

To date, there have been more than 360 insurance reform laws specific to dental care that have been enacted by states to protect patients and providers from abusive practices by insurers and third-party administrators. The continued growth of “self-funded plans” over “fully insured plans” and confusion over which laws carriers must abide by has prompted the ADA to seek federal legislation to address this confusion.

“ERISA’s original intent was to protect retirement plan assets like 401k, 403b or pensions,” said Dr. Rosato. “It wasn’t meant to let carriers ignore state laws and weaken consumer protections. We want carriers to follow the law and stop claiming ERISA as a reason to ignore the insurance reform efforts within our states.”

ERISA also regulates plan administrators and establishes minimum standards for pension plans and private industry. This legislative fix would not impact those employer-sponsored benefits.

For more information on the benefits of ERISA reform, visit ADA.org/ERISA.

About the American Dental Association

The not-for-profit ADA is the nation’s largest dental association, representing 159,000 dentist members. The premier source of oral health information, the ADA has advocated for the public’s health and promoted the art and science of dentistry since 1859. The ADA’s state-of-the-art research facilities develop and test dental products and materials that have advanced the practice of dentistry and made the patient experience more positive. The ADA Seal of Acceptance long has been a valuable and respected guide to consumer dental care products. The Journal of the American Dental Association (JADA), published monthly, is the ADA’s flagship publication and the best-read scientific journal in dentistry. For more information about the ADA, visit ADA.org . For more information on oral health, including prevention, care and treatment of dental disease, visit the ADA’s consumer website MouthHealthy.org